Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Henry Schein, Inc.    HSIC

HENRY SCHEIN, INC.

(HSIC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Henry Schein : Announces Participation in Upcoming Virtual Conferences in December

11/17/2020 | 08:04am EST

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following virtual investor conferences in December:

  • Piper Sandler 32nd Annual Healthcare Conference on December 1, 2020, at 1:00 p.m. Eastern time.
  • Evercore ISI 3rd Annual HealthCONx Virtual Conference on December 2, 2020, at 10:30 a.m. Eastern time.
  • Nasdaq 43rd Virtual Investor Conference on December 4, 2020, at 11:30 a.m. Eastern time.

Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations.

About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $10.0 billion in 2019, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.


© Business Wire 2020
All news about HENRY SCHEIN, INC.
01/05HENRY SCHEIN : Acquires Majority Stake in Prism Medical Products, Marking Entran..
MT
01/05HENRY SCHEIN : Acquires Majority Interest in Prism Medical Products, Enters Home..
BU
01/04HENRY SCHEIN : Baird Upgrades Henry Schein to Outperform From Neutral, Adjusts P..
MT
01/04HENRY SCHEIN : Completes Joint Venture with Casa Schmidt
BU
2020HENRY SCHEIN, INC., II : Post-Argument Analysis
AQ
2020HENRY SCHEIN : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
2020HENRY SCHEIN : Medical Enhances Access to Ansell Isolation Gowns Amid COVID-19, ..
BU
2020HENRY SCHEIN : Medical Helps Automate and Streamline Patient Waiting Room Proces..
BU
2020HENRY SCHEIN : to Ring the Nasdaq Stock Market Opening Bell
BU
2020HENRY SCHEIN : Arbitrability Returns To The Supreme Court In Henry Schein, Inc. ..
AQ
More news
Financials (USD)
Sales 2020 9 832 M - -
Net income 2020 400 M - -
Net Debt 2020 410 M - -
P/E ratio 2020 24,1x
Yield 2020 -
Capitalization 9 772 M 9 772 M -
EV / Sales 2020 1,04x
EV / Sales 2021 0,90x
Nbr of Employees 19 000
Free-Float 98,6%
Chart HENRY SCHEIN, INC.
Duration : Period :
Henry Schein, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HENRY SCHEIN, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 71,00 $
Last Close Price 68,44 $
Spread / Highest target 31,5%
Spread / Average Target 3,74%
Spread / Lowest Target -13,8%
EPS Revisions
Managers and Directors
NameTitle
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski Vice Chairman & President
Steven Paladino Chief Financial Officer, Director & Executive VP
Christopher Pendergast Chief Technology Officer & Senior Vice President
Philip A. Laskaway Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN, INC.2.36%9 772
CANTEL MEDICAL CORP.1.45%3 319
AS ONE CORPORATION-6.80%2 969
SHIP HEALTHCARE HOLDINGS, INC.3.31%2 702
OWENS & MINOR, INC.-4.07%1 908
JAPAN MEDICAL DYNAMIC MARKETING, INC.-0.55%599